Latest Orphan drug Stories
PARIS, June 23, 2014 /PRNewswire/ -- Pharnext SAS today announced that the European Medicines Agency (EMA) and the U.S.
In an environment where orphan drug development is on an all-time high and Contract Research Organizations are in demand, orphan reach, who pioneer a unique global patient access solution, has
LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Hot topics on Wednesday, June 18 SAN DIEGO (PRWEB) June 14, 2014 Patient perspective in clinical trials, efforts of the Food and Drug Administration
DOYLESTOWN, Pa., June 10, 2014 /PRNewswire/ -- On June 2, 2014 Makindus, Inc. a specialty pharmaceutical company, received orphan drug designation for their lead product MI-100 from the U.S.
EPI-743 in phase 2B development for Leigh syndrome MOUNTAIN VIEW, Calif., June 9, 2014 /PRNewswire/ -- Edison Pharmaceuticals today announced that the FDA has granted Orphan Drug status
Sessions to provide international perspectives and reveal new collaborative approaches. Washington (PRWEB) June 04, 2014 The world’s foremost drug
EPI-743 in phase 2B/3 development for Leigh syndrome MOUNTAIN VIEW, Calif., May 21, 2014 /PRNewswire/ -- Edison Pharmaceuticals today announced that the Japanese Ministry of Health,
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
New Kauffman Foundation paper highlights solutions to speed patients’ access to drugs with therapeutic value for more than one disease. Kansas City, MO (PRWEB)
- A political dynamiter.